Genscript Biotech Corp (OTCPK:GNNSF)
$ 1.41 0 (0%) Market Cap: 3.08 Bil Enterprise Value: 1.57 Bil PE Ratio: 0 PB Ratio: 2.52 GF Score: 69/100

Genscript Biotech Corp Business Update Meeting Transcript

Aug 02, 2020 / 11:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the GenScript Biotech Business Update Meeting. (Operator Instructions). Please be advised that today's conference is being recorded. I would now like to hand the call over to your host today, Mr. Shiniu Wei. Thank you. Sir, please go ahead.

Shiniu Wei
Genscript Biotechnology - VP, Investor Relations

Thank you, operator. Good morning, everyone. Thanks for attending GenScript business update conference call. I'm Shiniu Wei, vice president of investor relations for GenScript.

Present today on the call we have Dr. Frank Zhang, chairman of the board of directors for GenScript, Sally Wang, executive director and president for GenScript, Dr. Patrick Liu, rotating CEO of GenScript.

Before we begin, I'd like to remind everyone that the company and the management team will be making forward-looking statements that are based on currently available information which are subject to change due to various risk factors.

Last night, we had made three public announcements with regard to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot